DAVIS, CALIF. — Arcadia Biosciences, Inc. has initiated a seek for a brand new chief govt officer, a transfer that coincides with the corporate’s growth into the buyer packaged items sector. Matthew Plavan, who has been CEO since 2019, will step down from the position as soon as a successor is known as.
Mr. Plavan joined Arcadia in 2016 as chief monetary officer and later was named president of Arcadia Specialty Genomics in February 2019.
“The progress now we have made in a remarkably quick time frame after planting the flag as a CPG firm has been extraordinary, and it’s a testomony to the expertise and dedication of our group,” Mr. Plavan stated. “”With a portfolio of plant-based, better-for-you meals and wellness merchandise now in place and underneath improvement, Arcadia is well-positioned to leverage its innovation-oriented heritage, elevate its manufacturers and additional penetrate the buyer well being and wellness classes. Having reached this pivotal level, the timing is smart to start the method of transitioning to a brand new chief with deep expertise operating profitable CPG organizations who will be capable of construct on the corporate’s momentum, speed up speed-to-market and capitalize on the large progress alternatives forward.”
Kevin Comcowich, chairman of Arcadia, lauded Mr. Plavan’s management over the previous three years.
“Matt has deftly led Arcadia via a crucial transformational part, as we transitioned our focus from creating to commercializing a portfolio of specialty wheat substances, whereas, on the similar time, buying and integrating extra meals and wellness manufacturers,” Mr. Comcowich stated. “His expertise, power and dedication — significantly within the face of a world pandemic — have paved the way in which for vital long-term progress and worth creation. We look ahead to his ongoing assist as we work towards this management transition and the passing of the baton to a CPG-industry veteran for Arcadia’s subsequent chapter.”